| 词条 | Bactericidal/permeability-increasing protein |
| 释义 |
| Name = bactericidal/permeability-increasing protein | caption = | image = | width = | HGNCid = 1095 | Symbol = BPI | AltSymbols = | EntrezGene = 671 | OMIM = 109195 | RefSeq = NM_001725 | UniProt = P17213 | PDB = | ECnumber = | Chromosome = 20 | Arm = q | Band = 11.23 | LocusSupplementaryData = }} Bactericidal/permeability-increasing protein (BPI) is a 456-residue (~50kDa) protein that is part of the innate immune system.[1] It belongs to family of lipid-binding serum glycoproteins. Distribution and functionBPI was initially identified in neutrophils, but is found in other tissues including the epithelial lining of mucous membranes.[2] It is an endogenous antibiotic protein with potent killing activity against Gram-negative bacteria. It binds to compounds called lipopolysaccharides produced by Gram-negative bacteria. Lipolysaccharides are potent activators of the immune system; however, BPI at certain concentrations can prevent this activation. BPI was discovered by Jerrold Weiss and Peter Elsbach at New York University Medical School. rBPI21Because lipopolysaccharides are potent inflammatory agents, and the action of antibiotics can result in the release of these compounds, the binding capacity of BPI was explored as a possible means of reducing injury. Xoma Ltd. developed a recombinant 21kDa portion of the BPI molecule called rBPI21, NEUPREX, or opebecan. In a trial, it was found to decrease the mortality of Gram-negative bacterial-induced sepsis.[3] Studies suggest that its binding activity is not the means by which it mediates its protective effect.[4] Studies show biological effects with Gram-positive bacteria[5] and even in infection by the protozoan, Toxoplasma gondii.[6] References1. ^{{cite journal | vauthors = Elsbach P | title = The bactericidal/permeability-increasing protein (BPI) in antibacterial host defense | journal = Journal of Leukocyte Biology | volume = 64 | issue = 1 | pages = 14–8 | date = July 1998 | pmid = 9665269 | url = http://www.jleukbio.org/cgi/reprint/64/1/14 | publisher = Wiley-Liss | format = pdf }} 2. ^{{cite journal | vauthors = Canny G, Levy O, Furuta GT, Narravula-Alipati S, Sisson RB, Serhan CN, Colgan SP | title = Lipid mediator-induced expression of bactericidal/ permeability-increasing protein (BPI) in human mucosal epithelia | journal = Proceedings of the National Academy of Sciences of the United States of America | volume = 99 | issue = 6 | pages = 3902–7 | date = March 2002 | pmid = 11891303 | pmc = 122621 | doi = 10.1073/pnas.052533799 | url = http://www.pnas.org/cgi/content/full/99/6/3902 | publisher = National Academy of Sciences }} 3. ^{{cite journal | vauthors = Levin M, Quint PA, Goldstein B, Barton P, Bradley JS, Shemie SD, Yeh T, Kim SS, Cafaro DP, Scannon PJ, Giroir BP | title = Recombinant bactericidal/permeability-increasing protein (rBPI21) as adjunctive treatment for children with severe meningococcal sepsis: a randomised trial. rBPI21 Meningococcal Sepsis Study Group | journal = Lancet | volume = 356 | issue = 9234 | pages = 961–7 | date = September 2000 | pmid = 11041396 | doi = 10.1016/S0140-6736(00)02712-4 | url = http://www.thelancet.com/journals/lancet/article/PIIS0140673600027124/abstract | publisher = Lancet Publishing Group | laydate = 2000-09-14 | laysource = Business Wire | laysummary = http://findarticles.com/p/articles/mi_m0EIN/is_2000_Sept_14/ai_65253242 }} 4. ^{{cite journal | vauthors = Schlag G, Redl H, Davies J, Scannon P | title = Protective effect of bactericidal/permeability-increasing protein (rBPI21) in baboon sepsis is related to its antibacterial, not antiendotoxin, properties | journal = Annals of Surgery | volume = 229 | issue = 2 | pages = 262–71 | date = February 1999 | pmid = 10024109 | pmc = 1191640 | doi = 10.1097/00000658-199902000-00015 | publisher = Lippincott Williams & Wilkins }} 5. ^{{cite journal | vauthors = Srivastava A, Casey H, Johnson N, Levy O, Malley R | title = Recombinant bactericidal/permeability-increasing protein rBPI21 protects against pneumococcal disease | journal = Infection and Immunity | volume = 75 | issue = 1 | pages = 342–9 | date = January 2007 | pmid = 17101667 | pmc = 1828387 | doi = 10.1128/IAI.01089-06 | publisher = American Society for Microbiology }} 6. ^{{cite journal | vauthors = Khan AA, Lambert LH, Remington JS, Araujo FG | title = Recombinant bactericidal/permeability-increasing protein (rBPI21) in combination with sulfadiazine is active against Toxoplasma gondii | journal = Antimicrobial Agents and Chemotherapy | volume = 43 | issue = 4 | pages = 758–62 | date = April 1999 | pmid = 10103177 | pmc = 89203 | url = http://aac.asm.org/cgi/content/abstract/43/4/758 | publisher = American Society for Microbiology | quotes = }} External links
|
| 随便看 |
|
开放百科全书收录14589846条英语、德语、日语等多语种百科知识，基本涵盖了大多数领域的百科知识，是一部内容自由、开放的电子版国际百科全书。